Asahi Life Asset Management Co., Ltd. Biogen Inc. Transaction History
Asahi Life Asset Management Co., Ltd.
- $161 Million
- Q4 2024
A detailed history of Asahi Life Asset Management Co., Ltd. transactions in Biogen Inc. stock. As of the latest transaction made, Asahi Life Asset Management Co., Ltd. holds 2,285 shares of BIIB stock, worth $344,372. This represents 0.22% of its overall portfolio holdings.
Number of Shares
2,285
Previous 1,800
26.94%
Holding current value
$344,372
Previous $348,000
0.29%
% of portfolio
0.22%
Previous 0.21%
Shares
15 transactions
Others Institutions Holding BIIB
# of Institutions
1,003Shares Held
131MCall Options Held
1.77MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.52 Billion0.05% of portfolio
-
Primecap Management CO Pasadena, CA16MShares$2.42 Billion1.94% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.19 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$1.11 Billion0.05% of portfolio
-
Wellington Management Group LLP Boston, MA4.93MShares$743 Million0.14% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $21.7B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...